Mounjaro has been associated with gastrointestinal adverse reactions, which involve nausea, vomiting, and diarrhea. These functions may possibly bring about dehydration, which if significant could cause acute kidney harm. In individuals treated with GLP-1 receptor agonists, there have been postmarketing reports of acute kidney injuries and worsenin